Results 141 to 150 of about 216,511 (181)
SF1 regulates the transcription of FDX1 to promote cuproptosis in pediatric sepsis-related acute lung injury by interacting with cJUN. [PDF]
Wang Y, Sun J, Zhang L, Zhou S, Zhao F.
europepmc +1 more source
ABSTRACT Hypoxia and nutrient deprivation are fundamental drivers of tumor aggressiveness and therapeutic resistance in hepatocellular carcinoma (HCC). While the involvement of neural components in the tumor microenvironment (TME) is increasingly recognized, the molecular transducers linking metabolic stress to neuron–tumor crosstalk remain elusive ...
Taehyun Park +5 more
wiley +1 more source
Eliminate <i>Mycobacterium tuberculosis</i> via HELZ2 and up-regulating ATG16L1 to promote macrophage autophagy. [PDF]
Wang T, Liu L, Lei Y.
europepmc +1 more source
Abstract Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor originating from calcitonin producing C‐cells and accounts for 1–5% of thyroid cancers. Total thyroidectomy is curative in localized disease (N0), whereas lymph node metastases (N1) are associated with poorer prognosis.
Anna Citarella +24 more
wiley +1 more source
Key Players and Pathways of Mast Cell Activation in Urticaria. [PDF]
Jahn C +4 more
europepmc +1 more source
Abstract Arogenate dehydratase (ADT) is a key enzyme in plant phenylalanine (Phe) biosynthesis, providing precursors for protein and phenolic compounds. Akebia trifoliata is valued as a medicinal, fruit, and ornamental plant because of its abundance of Phe and derivatives.
Jie Li +10 more
wiley +1 more source
The NSDHL/c-Myc/PKM2 Axis Drives Glycolytic Reprogramming and Tumor Growth in Multiple Myeloma. [PDF]
Yue C, Huang BH, Qi L, Zhang XD, Li J.
europepmc +1 more source
Emerging Roles of PSTPIP2 in Autoimmunity: From Mechanism to Therapeutic Implications
PSTPIP2 acts as a key brake on myeloid inflammation by suppressing IL‐1β‐driven signalling, macrophage dysregulation and inflammation‐associated bone remodelling. Its emerging roles in CRMO/CMO, rheumatoid arthritis, SAPHO syndrome and bullous pemphigoid support its potential as a biomarker and therapeutic target.
Erdong Zhang +9 more
wiley +1 more source
Targeting adaptive EGFR feedback enhances the therapeutic efficacy of RMC-6236 in cholangiocarcinoma. [PDF]
Yamazaki S +12 more
europepmc +1 more source

